Royal Healthcare in Singapore provides NEC’s “FonesVisuas Test” for Disease Risk Prediction

Avatar photo

- Writer

Thursday, 26 March 2026 - 02:00

facebook twitter whatsapp telegram line copy

URL berhasil dicopy

facebook icon twitter icon whatsapp icon telegram icon line icon copy

URL berhasil dicopy

TOKYO, March 26, 2026 /PRNewswire/ — NEC Corporation (NEC; TSE: 6701) announced that its FonesVisuas Test, an innovative blood test that predicts disease risk, is being offered by Royal Healthcare (*1), a Singapore-based medical institution and group company of Sojitz Corporation that combines the latest medical expertise with the art of hospitality.

Entrance of the Specialist Medical Centre
Entrance of the Specialist Medical Centre

According to the World Health Organization (WHO), the global rise in lifestyle-related diseases and dementia underscores the urgency for advanced predictive diagnostics (*2). Concurrently, the Organisation for Economic Co-operation and Development (OECD) iLibrary data has identified cancer and cardiovascular diseases as leading causes of mortality worldwide (*3), amplifying the urgency for proactive health management solutions.

Royal Healthcare is based in Singapore’s medical hub, Novena, providing personalized, high-quality health screening services alongside customized medical experiences that prioritize efficiency and convenience for both local and international patients.

Interior of the Specialist Medical Centre
Interior of the Specialist Medical Centre

The addition of the FonesVisuas Test represents a significant advancement by analyzing proteins that reflect dynamic physiological changes. From just a small blood sample, the test can predict risks of developing conditions such as dementia, heart attack, lung cancer, chronic kidney disease, and prostate cancer over the next several years.

Royal Healthcare combines its services with conventional health checkups to guide individuals who are not yet ill but also not in optimal health toward lifestyle improvements. This approach aims to prevent future illness and enhance people’s quality of life.

Looking ahead, NEC plans to expand provision of the FonesVisuas Test internationally, particularly in the APAC region, underscoring its commitment to advancing global healthcare standards.

Notes

(*1) https://royal-healthcare.com/
(*2) https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases; https://www.who.int/news-room/fact-sheets/detail/dementia
(*3) https://www.oecd-ilibrary.org/social-issues-migration-health/health-at-a-glance-2023_7a7afb35-en

About NEC

The NEC Group leverages technology to create social value and promote a more sustainable world where everyone has the chance to reach their full potential. NEC Corporation was established in 1899. Today, the NEC Group’s approximately 110,000 employees utilize world-leading AI, security, and communications technologies to solve the most pressing needs of customers and society.

For more information, please visit https://www.nec.com, and follow us on Instagram, Facebook, YouTube, and LinkedIn.

Berita Terkait

Global Sources Hong Kong Shows Phase II Officially Opens, AI Products Go Mainstream as Humanoid Robot Zone Makes Its Debut
Antengene Presents Three Novel Programs at AACR 2026, Highlighting Next-Generation ADC and AnTenGager® TCEs
AGIBOT Unveils New Generation of Embodied AI Robots and Models, Accelerating Real-World Deployment of Physical AI
AGIBOT Declares 2026 “Deployment Year One” at APC 2026, Accelerating the Era of Embodied AI Productivity
Shanghai Electric Reports Strong 2025 Performance, New Orders Hit Record High
iQIYI Deepens Its Presence at BIFF With AI Agent Nadou Pro and a New Film Screening
Chula Launches 2026 “Chula LINK Scholarship” for International Graduate Students
Ant International, IFC, GCash pioneer first-of-its-kind sustainability impact scorecard to expand MSME access to sustainable financing

Berita Terkait

Saturday, 18 April 2026 - 12:56

Global Sources Hong Kong Shows Phase II Officially Opens, AI Products Go Mainstream as Humanoid Robot Zone Makes Its Debut

Saturday, 18 April 2026 - 00:30

Antengene Presents Three Novel Programs at AACR 2026, Highlighting Next-Generation ADC and AnTenGager® TCEs

Friday, 17 April 2026 - 18:16

AGIBOT Unveils New Generation of Embodied AI Robots and Models, Accelerating Real-World Deployment of Physical AI

Friday, 17 April 2026 - 18:11

AGIBOT Declares 2026 “Deployment Year One” at APC 2026, Accelerating the Era of Embodied AI Productivity

Friday, 17 April 2026 - 14:13

Shanghai Electric Reports Strong 2025 Performance, New Orders Hit Record High

Berita Terbaru